Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 79

1.

Significance of measurement of serum trough level and anti-drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial.

Nakase H, Motoya S, Matsumoto T, Watanabe K, Hisamatsu T, Yoshimura N, Ishida T, Kato S, Nakagawa T, Esaki M, Nagahori M, Matsui T, Naito Y, Kanai T, Suzuki Y, Nojima M, Watanabe M, Hibi T; DIAMOND study group.

Aliment Pharmacol Ther. 2017 Sep 8. doi: 10.1111/apt.14318. [Epub ahead of print]

PMID:
28884856
2.

A case of cytomegalovirus infection with splenic infarction and an esophageal ulcer in an immunocompetent adult.

Shimizu Y, Komura T, Seike T, Nakai R, Omura H, Kagaya T, Ohta H, Kasashima S, Kawashima A, Unoura M.

Nihon Shokakibyo Gakkai Zasshi. 2017;114(7):1269-1276. doi: 10.11405/nisshoshi.114.1269.

PMID:
28679983
3.

A rapidly growing, large, mature retroperitoneal teratoma in an adult male patient.

Seike T, Kagaya T, Komura T, Nakai R, Shimizu Y, Omura H, Ohta H, Ohyama S, Kawashima A, Unoura M.

Nihon Shokakibyo Gakkai Zasshi. 2017;114(6):1008-1014. doi: 10.11405/nisshoshi.114.1008.

PMID:
28579584
4.

Lidocaine spray alone is similar to spray plus viscous solution for pharyngeal observation during transoral endoscopy: a clinical randomized trial.

Hayashi T, Asahina Y, Waseda Y, Kitamura K, Kagaya T, Seike T, Okada K, Inada Y, Takabatake H, Orita N, Yanase Y, Yamashita T, Ninomiya I, Yoshimura K, Kaneko S.

Endosc Int Open. 2017 Jan;5(1):E47-E53. doi: 10.1055/s-0042-120414.

5.

Efficacy of a diagnostic and therapeutic algorithm for Clostridium difficile infection.

Marukawa Y, Komura T, Kagaya T, Ohta H, Unoura M.

Nihon Shokakibyo Gakkai Zasshi. 2016 Aug;113(8):1386-92. doi: 10.11405/nisshoshi.113.1386.

PMID:
27498935
6.

Cytomegalovirus Reactivation Induced Acute Hepatitis and Gastric Erosions in a Patient with Rheumatoid Arthritis under Treatment with an Anti-IL-6 Receptor Antibody, Tocilizumab.

Komura T, Ohta H, Nakai R, Seishima J, Yamato M, Miyazawa M, Kaji K, Marukawa Y, Kagaya T, Kitagawa K, Kawashima A, Kaneko S, Unoura M.

Intern Med. 2016;55(14):1923-7. doi: 10.2169/internalmedicine.55.5981. Epub 2016 Jul 15.

7.

Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan.

Komoto S, Motoya S, Nishiwaki Y, Matsui T, Kunisaki R, Matsuoka K, Yoshimura N, Kagaya T, Naganuma M, Hida N, Watanabe M, Hibi T, Suzuki Y, Miura S, Hokari R; Japanese study group for pregnant women with IBD.

Intest Res. 2016 Apr;14(2):139-45. doi: 10.5217/ir.2016.14.2.139. Epub 2016 Apr 27.

8.

An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's disease.

Yoshimura N, Yokoyama Y, Matsuoka K, Takahashi H, Iwakiri R, Yamamoto T, Nakagawa T, Fukuchi T, Motoya S, Kunisaki R, Kato S, Hirai F, Ishiguro Y, Tanida S, Hiraoka S, Mitsuyama K, Ishihara S, Tanaka S, Otaka M, Osada T, Kagaya T, Suzuki Y, Nakase H, Hanai H, Watanabe K, Kashiwagi N, Hibi T.

BMC Gastroenterol. 2015 Nov 19;15:163. doi: 10.1186/s12876-015-0390-3.

9.

[A case of autoimmune pancreatitis associated with hemorrhagic duodenal ulcers].

Miyazawa M, Takatori H, Arai K, Kawaguchi K, Kitamura K, Kagaya T, Yamashita T, Sakai Y, Zen Y, Kaneko S.

Nihon Shokakibyo Gakkai Zasshi. 2015 Apr;112(4):699-706. doi: 10.11405/nisshoshi.112.699. Japanese.

PMID:
25843458
10.

[A case of Wilson's disease in an elderly patient initially diagnosed with NASH].

Seishima J, Sakai Y, Kitahara N, Kitamura K, Arai K, Kagaya T, Yamashita T, Mizukoshi E, Honda M, Kaneko S.

Nihon Shokakibyo Gakkai Zasshi. 2015 Feb;112(2):317-24. doi: 10.11405/nisshoshi.112.317. Japanese.

PMID:
25748158
11.

[A case of chronic hepatitis B with liver failure due to untreated Basedow disease].

Shimizu Y, Kitahara M, Yamashita T, Arai K, Yamashita T, Kagaya T, Sakai Y, Mizukoshi E, Honda M, Kaneko S.

Nihon Shokakibyo Gakkai Zasshi. 2015 Jan;112(1):94-100. doi: 10.11405/nisshoshi.112.94. Japanese.

PMID:
25744925
12.

Autoimmune pancreatitis complicated with inflammatory bowel disease and comparative study of type 1 and type 2 autoimmune pancreatitis.

Kawa S, Okazaki K, Notohara K, Watanabe M, Shimosegawa T; Study Group for Pancreatitis Complicated with Inflammatory Bowel Disease organized by The Research Committee for Intractable Pancreatic Disease (Chairman: Tooru Shimosegawa) and The Research Committee for Intractable Inflammatory Bowel Disease (Chairman: Mamoru Watanabe), both of which are supported by the Ministry of Health, Labour, and Welfare of Japan.

J Gastroenterol. 2015 Jul;50(7):805-15. doi: 10.1007/s00535-014-1012-5. Epub 2014 Nov 16.

PMID:
25399203
13.

Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy.

Terashima T, Yamashita T, Iida N, Yamashita T, Nakagawa H, Arai K, Kitamura K, Kagaya T, Sakai Y, Mizukoshi E, Honda M, Kaneko S.

Hepatol Res. 2014 Oct 16. doi: 10.1111/hepr.12436. [Epub ahead of print]

PMID:
25319848
14.

[Diagnostic benefits of adrenocortical scintigraphy in hepatic adrenal rest tumor].

Ishida K, Horii R, Yamashita T, Arai K, Yamashita T, Kagaya T, Sakai Y, Mizukoshi E, Honda M, Kaneko S.

Nihon Shokakibyo Gakkai Zasshi. 2014 Oct;111(10):2004-12. Review. Japanese.

PMID:
25283230
15.

P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinoma.

Terashima T, Mizukoshi E, Arai K, Yamashita T, Yoshida M, Ota H, Onishi I, Kayahara M, Ohtsubo K, Kagaya T, Honda M, Kaneko S.

Cancer Immunol Immunother. 2014 May;63(5):479-89. doi: 10.1007/s00262-014-1529-8. Epub 2014 Mar 16.

PMID:
24633336
16.

Feasibility and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma after sorafenib.

Terashima T, Yamashita T, Arai K, Sunagozaka H, Kitahara M, Nakagawa H, Kagaya T, Mizukoshi E, Honda M, Kaneko S.

Hepatol Res. 2014 Nov;44(12):1179-85. doi: 10.1111/hepr.12266. Epub 2014 Jan 8.

PMID:
24171787
17.

Hematologic malignancies in the Japanese patients with inflammatory bowel disease.

Fukata N, Okazaki K, Omiya M, Matsushita M, Watanabe M; Members of the Ministry of Health and Welfare of Japan’s Inflammatory Bowel Diseases Study Group.

J Gastroenterol. 2014 Sep;49(9):1299-306. doi: 10.1007/s00535-013-0873-3. Epub 2013 Aug 19.

PMID:
23955181
18.

A novel truncated glucagon-like peptide 2 (GLP-2) as a tool for analyzing GLP-2 receptor agonists.

Yamazaki K, Kagaya T, Watanabe M, Terauchi H, Iida D, Fukumoto H, Suzuki S, Arai T, Aoki M, Takase K, Seiki T, Tsukahara K, Nagakawa J.

Biomed Res. 2013 Jun;34(3):129-36.

19.

Field surveys can support ecological risk assessment.

Iwasaki Y, Kagaya T, Ormerod SJ.

Integr Environ Assess Manag. 2013 Jan;9(1):171-2. doi: 10.1002/ieam.1378. No abstract available.

PMID:
23281239
20.

Species-specific differences in agonistic activity of ago-allosteric modulators toward glucagon-like peptide 2 receptor.

Yamazaki K, Takase K, Watanabe M, Kagaya T, Terauchi H, Iida D, Fukumoto H, Suzuki S, Arai T, Aoki M, Seiki T, Tsukahara K, Nagakawa J.

Biomed Res. 2012 Dec;33(6):337-44.

Supplemental Content

Loading ...
Support Center